JACKSON CENTER, PA / ACCESSWIRE / October 27, 2022 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO William A. Hartman and Chief Technology Officer, Dr. Mitchell S. Felder, interviewed on "The Street Reports," speaking about significant milestones which their research demonstrated, how it could revolutionize the healthcare sector and the potential effects it could have on the treatment of numerous diseases.
Listen here: https://thestreetreports.com/the-street-reports-podcast-features-halberd-corporations-otc-halb-ceo-william-hartman-and-chief-technology-officer-dr-mitchell-s-felder-listen-now/
To get the latest news on Halberd's exciting developments, subscribe by submitting this.
For more information please contact:
William A. Hartman
About Halberd Corporation.
Halberd Corporation (OTC-PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. Since its restructuring in April of 2020, Halberd has obtained exclusive worldwide rights to three issued patents and has filed 22 related provisional, PCT, or utility patent applications to enhance its value to its stockholders and to attract the interests of potential development partners.
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Company' cautions our readers that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time the statements are made. These statements may address issues that involve significant risks, uncertainties and associated estimates made by management. Actual results could differ materially from current projections or implied results. Halberd Corporation undertakes no obligation to revise these statements following the date of this news release.
SOURCE: Halberd Corporation